Psychopharmacology and Psychiatry Updates
Podcast tekijän mukaan Psychopharmacology Institute
Kategoriat:
265 Jaksot
-
Beyond the Pain: Diagnosing Fibromyalgia
Julkaistiin: 17.5.2024 -
Informed Consent and SSRIs: Discussing the Risk of Irreversible Sexual Side Effects
Julkaistiin: 11.5.2024 -
Mastering Clozapine: Adverse Effect Management
Julkaistiin: 6.5.2024 -
Preventing Depression and Anxiety Relapse in Youth
Julkaistiin: 1.5.2024 -
Charting the Clozapine Course: Titration and Monitoring
Julkaistiin: 26.4.2024 -
Smoking and Psychosis: Insights from the PATH Study
Julkaistiin: 21.4.2024 -
Clozapine: The Gold Standard for Treatment-Resistant Schizophrenia
Julkaistiin: 16.4.2024 -
Balancing Benefits and Risks: Lithium in Child and Adolescent Psychiatry
Julkaistiin: 11.4.2024 -
Orchestrating Nutrition and Medication: Micronutrient Therapy in Practice
Julkaistiin: 6.4.2024 -
Zuranolone: A New Dawn for Postpartum Depression Treatment
Julkaistiin: 1.4.2024 -
Micronutrients for Psychiatric Disorders: Optimizing Clinical Use
Julkaistiin: 27.3.2024 -
Olanzapine in Pregnancy: Examining the Risks
Julkaistiin: 22.3.2024 -
Understanding Safety Risks of Broad-Spectrum Micronutrients
Julkaistiin: 17.3.2024 -
The Role of Inflammation in Delirium: Can NSAIDs Help?
Julkaistiin: 12.3.2024 -
Beyond Medication: Exploring Nutritional Psychiatry
Julkaistiin: 7.3.2024 -
Age Impact on Antidepressant Outcomes
Julkaistiin: 2.3.2024 -
Dealing With Delirium in Patients With Advanced Cancer
Julkaistiin: 26.2.2024 -
Rechallenging Clozapine: A Look at Colony Stimulating Factors
Julkaistiin: 21.2.2024 -
Managing Anxiety in Patients With Cancer
Julkaistiin: 16.2.2024 -
Managing Antidepressant Side Effects in Youth
Julkaistiin: 11.2.2024
Practical psychopharmacology updates for mental health clinicians. Useful for psychiatry / mental health professionals. Expert interviews and soundbites from CME presentations. Practical and free of commercial bias. Not sponsored by any pharmaceutical company.
